Literature DB >> 22664292

Stepwise revascularization by carotid endarterectomy after balloon angioplasty for symptomatic severe carotid artery stenosis.

Yusuke Egashira1, Shinichi Yoshimura, Kiyofumi Yamada, Yukiko Enomoto, Takahiko Asano, Toru Iwama.   

Abstract

The authors report a novel stepwise carotid revascularization method to prevent perioperative complication. A 68-year-old man presented with left hemiparesis and dysarthria caused by severe stenosis of the right cervical internal carotid artery. According to the preoperative cerebral blood flow evaluation and plaque characterization, the patient was at risk for postoperative hyperperfusion and ischemic complications after carotid artery stenting. Initially, the patient underwent percutaneous angioplasty using an undersized balloon. Fifteen days later, the patient underwent a carotid endarterectomy. The surgical specimen obtained during the carotid endarterectomy showed the presence of typical vulnerable plaque. Of note was the complete preservation of the thin fibrous cap. The postoperative single-photon emission tomography images showed no signs of hyperperfusion, and the patient developed no neurological symptoms after each of the procedures.
Copyright © 2012 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22664292     DOI: 10.1016/j.avsg.2011.10.021

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Therapeutic strategy of severe circular calcified carotid plaque with hemodynamic impairment: A patient treated by carotid endarterectomy following balloon angioplasty to prevent hyperperfusion.

Authors:  Takaki Marutani; Daina Kashiwazaki; Shusuke Yamamoto; Naoki Akioka; Emiko Hori; Satoshi Kuroda
Journal:  Surg Neurol Int       Date:  2022-08-12

2.  Experience of Staged Angioplasty to Avoid Hyperperfusion Syndrome for Carotid Artery Stenosis.

Authors:  Kazutaka Uchida; Shinichi Yoshimura; Manabu Shirakawa; Seigo Shindo; Yusuke Egashira; Toru Iwama; Kiyofumi Yamada
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-10-08       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.